OTCMKTS:HSDT

Helius Medical Technologies Stock Insider Trading

Healthcare > Medical - Devices

Buy HSDT

*Your capital is at risk

$1.71

-0.0400 (-2.29%)

At Close: Jul 13, 2026

Helius Medical Technologies Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 43.99M and sold 2.91M HSDT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	43.99M shares
● Sell	2.91M shares
97% Buy Activity Moderate Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 02, 2026 Sell	Common Stock F-InKind	Jiang Cosmo Yi Director	Director	610 Value: $1K
Jun 02, 2026 Buy	Common Stock M-Exempt	Jiang Cosmo Yi Director	Director	1 005 040 Value: $1K
Jun 02, 2026 Buy	Warrant (Right to Buy) M-Exempt	Jiang Cosmo Yi Director	Director	1 005 040 Value: $1K
May 21, 2026 Buy	Class A Common Stock A-Award	Walter Blane Director	Director	6 360 Value: $15.0K
May 21, 2026 Buy	Stock Option (Right to Buy) A-Award	Walter Blane Director	Director	18 564 Value: $43.8K
May 21, 2026 Buy	Class A Common Stock A-Award	Straw Edward M Director	Director	6 360 Value: $15.0K
May 21, 2026 Buy	Stock Option (Right to Buy) A-Award	Mello Sergio Director	Director	18 564 Value: $43.8K
May 21, 2026 Buy	Class A Common Stock A-Award	Mello Sergio Director	Director	6 360 Value: $15.0K
May 21, 2026 Buy	Stock Option (Right to Buy) A-Award	Lee Michel Kai Tai Director	Director	18 564 Value: $43.8K
May 21, 2026 Buy	Class A Common Stock A-Award	Lee Michel Kai Tai Director	Director	6 360 Value: $15.0K
May 21, 2026 Buy	Stock Option (Right to Buy) A-Award	Straw Edward M Director	Director	18 564 Value: $43.8K
May 11, 2026 Sell	Class A Common Stock J-Other	Summer Wisdom Holdings Ltd 10 Percent Owner	10% Owner	1 453 277 Value: $0
May 11, 2026 Sell	Class A Common Stock J-Other	Fusion Summer Ltd 10 Percent Owner	10% Owner	1 453 277 Value: $0
May 11, 2026 Buy	Restricted Stock Unit Award M-Exempt	Chee Choon Wee Executive Chairman	CEO / President	1 109 118 Value: $2.47M
May 11, 2026 Buy	Class A Common Stock M-Exempt	Chee Choon Wee Executive Chairman	CEO / President	1 109 118 Value: $2.47M
Apr 23, 2026 Buy	Common Stock J-Other	Mello Sergio Insider	Other	0 Value: $0
Apr 23, 2026 Buy	Common Stock J-Other	Lee Michel Kai Tai Insider	Other	0 Value: $0
Apr 06, 2026 Buy	Common Stock J-Other	Tjandrasuwita Agustina Gani Insider	Other	0 Value: $0
Mar 31, 2026 Buy	Class A Common Stock A-Award	Walter Blane Director	Director	2 180 Value: $4K
Mar 31, 2026 Buy	Class A Common Stock A-Award	Straw Edward M Director	Director	2 180 Value: $4K
Mar 31, 2026 Buy	Stock Option (Right to Buy) A-Award	Walter Blane Director	Director	23 529 Value: $161.9K
Mar 31, 2026 Buy	Class A Common Stock A-Award	Walter Blane Director	Director	2 180 Value: $4K
Mar 31, 2026 Buy	Class A Common Stock A-Award	Perkins Sherrie L Director	Director	2 180 Value: $4K
Mar 31, 2026 Buy	Stock Option (Right to Buy) A-Award	Perkins Sherrie L Director	Director	23 529 Value: $161.9K
Mar 31, 2026 Buy	Class A Common Stock A-Award	Buckman Paul Director	Director	2 180 Value: $4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT HELIUS MEDICAL TECHNOLOGIES, INC.

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic...

Read Full Profile Here